Smoking cessation drug could help young people quit vaping, study results suggest Researchers found that varenicline is an effective vaping cessation drug among participants aged 16–25 years who vape nicotine daily or near daily.…
Neonatal sepsis: prevention and management The third article in a series on complications associated with prematurity and unwell neonates.…
NICE reverses draft guidance to recommend targeted therapy for patients with advanced bowel cancer The National Institute for Health and Care Excellence said the treatment should be available on the NHS after the manufacturer provided additional clinical evidence.…
Antibiotic could help tackle drug-resistant gonorrhoea, study results suggest Researchers found that gepotidacin was as effective as the current recommended first-line therapy for gonorrhoea.…
NICE recommends cladribine for treating active relapsing forms of multiple sclerosis Cladribine (Mavenclad; Merck) is recommended for treating active relapsing-remitting multiple sclerosis in adults when high-efficacy disease-modifying therapies would be offered.…
Earlier treatment with combination of drugs could prevent 5,000 heart attacks per decade, study results suggest Researchers found that patients who received a combination treatment of statins and ezetimibe within 12 weeks of a heart attack and lowered their cholesterol to target-level early were less at risk of heart attacks, strokes and deaths.…
How do we solve a problem like medicines adherence? Despite decades of research, rates of adherence to medicines remain stubbornly low. New ways of thinking and innovative use of technology may help us turn a corner.…
Community pharmacy RSV expansion programme to be expanded four-fold The Department of Health and Social Care said up to 200 community pharmacy sites could be commissioned to provide the respiratory syncytial virus vaccination in 2025/2026.…
Premature birth: managing associated complications Part of a series of articles on the management of prematurity associated complications and the role of pharmacists.…
NICE recommends capivasertib for advanced breast cancer Clinical trial results revealed that capivasertib, taken with fulvestrant, can provide advanced breast cancer patients with an additional four months before their cancer progresses.…
